AVNS AVANOS MEDICAL, INC.
Last updated: May 11, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 4/4 quarters. Q1 2026: $2M, Q3 2025: $0M, Q2 2025: $4M, Q1 2025: $9M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $2M vs trailing avg $4M (-48%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.
Negative FCF ($-29M), buybacks not supported by cash flow
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 1,370,720 shares = 3.0% of 46,456,462 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
2 open-market purchases by 1 insiders
- BLACKFORD GARY () bought 20,000 shares at $10.97 on 2025-08-13
- BLACKFORD GARY () bought 40,000 shares at $10.99 on 2025-08-13
Insider-Buyback Convergence
Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.
Company buybacks in 4 quarters and 2 insider purchases by 1 insiders (no calendar overlap, but both independently active)
Insider Net Direction
Over the last 90 days, are insiders net buyers or net sellers on the open market?
Insiders bought $0M, sold $0M in the last 90 days (net selling)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
No buyback-insider divergence detected